Sanofi
SNY
#124
Rank
NZ$218.00 B
Marketcap
$86.04
Share price
0.92%
Change (1 day)
12.90%
Change (1 year)

Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthรฉlabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.

Sanofi (SNY) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$42.34 Billion

According to Sanofi's latest financial reports the company's total debt is NZ$42.34 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sanofi - Total debt on balance sheet (from 2002 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$32.20 B-10.14%
2022-12-31NZ$35.83 B-3.57%
2021-12-31NZ$37.16 B-2.74%
2020-12-31NZ$38.20 B-11.42%
2019-12-31NZ$43.13 B2.65%
2018-12-31NZ$42.02 B59.44%
2017-12-31NZ$26.35 B-6.58%
2016-12-31NZ$28.21 B6.68%
2015-12-31NZ$26.44 B15.01%
2014-12-31NZ$22.99 B-6.22%
2013-12-31NZ$24.51 B4.94%
2012-12-31NZ$23.36 B-9.05%
2011-12-31NZ$25.68 B80.39%
2010-12-31NZ$14.24 B-18.21%
2009-12-31NZ$17.41 B20.34%
2008-12-31NZ$14.46 B27.76%
2007-12-31NZ$11.32 B-12.93%
2006-12-31NZ$13.00 B-32.8%
2005-12-31NZ$19.35 B-36.49%
2004-12-31NZ$30.47 B4180.02%
2003-12-31NZ$0.71 B-14.4%
2002-12-31NZ$0.83 B-3.19%
2001-12-31NZ$0.85 B-1.9%
2000-12-31NZ$0.87 B-1.33%
1999-12-31NZ$0.88 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$62.85 B 48.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$114.23 B 169.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$85.49 B 101.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$53.49 B 26.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$35.74 B-15.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$31.47 B-25.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$59.46 B 40.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$51.76 B 22.23%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.66 B-67.74%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
NZ$24.91 B-41.17%๐Ÿ‡บ๐Ÿ‡ธ USA